MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
55.24
-0.41 (-0.74%)
Aug 14, 2025, 11:31 AM - Market open

MLTX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
306.68180.43451.1739.518.04
Short-Term Investments
118.4267.659.8432.61-
Cash & Short-Term Investments
425.08448.03511.0172.118.04
Cash Growth
-18.22%-12.32%608.60%797.08%-
Other Receivables
3.412.841.060.220.15
Receivables
3.412.841.060.220.15
Prepaid Expenses
26.9923.422.14.181.45
Total Current Assets
455.48474.29514.1776.519.64
Property, Plant & Equipment
2.923.643.950.330.05
Other Long-Term Assets
--8.42--
Total Assets
460.1477.93526.5476.849.68
Accounts Payable
0.60.220.330.160.03
Accrued Expenses
24.3720.238.077.244.76
Short-Term Debt
----15
Current Portion of Leases
1.551.371.20.15-
Current Income Taxes Payable
0.840.640.370.110.06
Other Current Liabilities
----1.23
Total Current Liabilities
27.3622.469.977.6721.09
Long-Term Leases
0.841.462.50.13-
Total Liabilities
102.1524.5413.058.0821.33
Common Stock
0.010.010.010.010.04
Additional Paid-In Capital
683.96677.41609.97129.1942.06
Retained Earnings
-330.76-235.59-116.66-80.65-53.64
Treasury Stock
-----0.01
Comprehensive Income & Other
0.5252.360.35-0.17
Total Common Equity
353.73446.83495.6848.9-11.72
Minority Interest
4.216.5717.8219.87-
Shareholders' Equity
357.94453.39513.4968.77-11.65
Total Liabilities & Equity
460.1477.93526.5476.849.68
Total Debt
75.772.833.70.2815
Net Cash (Debt)
349.32445.2507.3171.83-6.96
Net Cash Growth
-32.36%-12.24%606.24%--
Net Cash Per Share
5.537.0810.332.45-0.89
Filing Date Shares Outstanding
63.563.2862.8739.150.3
Total Common Shares Outstanding
63.4763.0860.4738.980.3
Working Capital
428.12451.82504.268.85-11.45
Book Value Per Share
5.577.088.201.25-38.57
Tangible Book Value
353.73446.83495.6848.9-11.72
Tangible Book Value Per Share
5.577.088.201.25-38.57
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q